145th ENMC International Workshop: Planning for an International Trial of Steroid Dosage Regimes in DMD (FOR DMD) - 22-24th October 2006, Naarden, the Netherlands

被引：12

作者：

Bushby, K.

Griggs, R.

机构：

[1] Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England

[2] Univ Rochester, Med Ctr, Rochester, NY 14642 USA

来源：

NEUROMUSCULAR DISORDERS | 2007年 / 17卷 / 05期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1016/j.nmd.2007.01.006

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：423 / 428

页数：6

共 31 条

[1]

Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology [J].

Alter, J ;

Lou, F ;

Rabinowitz, A ;

Yin, HF ;

Rosenfeld, J ;

Wilton, SD ;

Partridge, TA ;

Lu, QL .

NATURE MEDICINE, 2006, 12 (02) :175-177

[2]

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease [J].

Atkinson M.J. ;

Sinha A. ;

Hass S.L. ;

Colman S.S. ;

Kumar R.N. ;

Brod M. ;

Rowland C.R. .

Health and Quality of Life Outcomes, 2 (1)

[3]

BEROUD C, 2006, HUM MUTAT

[4]

Bone mineral density and bone metabolism in Duchenne muscular dystrophy [J].

Bianchi, ML ;

Mazzanti, A ;

Galbiati, E ;

Saraifoger, S ;

Dubini, A ;

Cornelio, F ;

Morandi, L .

OSTEOPOROSIS INTERNATIONAL, 2003, 14 (09) :761-767

[5]

BIGGAR LK, 2005, NEUROMUSCULAR DISORD, V15, P80

[6]

Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade [J].

Biggar, WD ;

Harris, VA ;

Eliasoph, L ;

Alman, B .

NEUROMUSCULAR DISORDERS, 2006, 16 (04) :249-255

[7]

Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols [J].

Biggar, WD ;

Politano, L ;

Harris, VA ;

Passamano, L ;

Vajsar, J ;

Alman, B ;

Palladino, A ;

Comi, LI ;

Nigro, G .

NEUROMUSCULAR DISORDERS, 2004, 14 (8-9) :476-482

[8]

Functional improvement of dystrophic muscle by myostatin blockade [J].

Bogdanovich, S ;

Krag, TOB ;

Barton, ER ;

Morris, LD ;

Whittemore, LA ;

Ahima, RS ;

Khurana, TS .

NATURE, 2002, 420 (6914) :418-421

[9]

Myostatin propeptide-mediated amelioration of dystrophic pathophysiology [J].

Bogdanovich, S ;

Perkins, KJ ;

Krag, TOB ;

Whittemore, SA ;

Khurana, TS .

FASEB JOURNAL, 2005, 19 (06) :543-549

[10]

Braun S, 2004, CURR OPIN MOL THER, V6, P499

← 1 2 3 4 →